Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Leidos was recently awarded a new prime contract to provide biomedical preclinical and development capabilities to support the National Institute of Allergy and Infectious Diseases (NIAID).
read more
Tuesday, February 03, 2015
Dr. Satyanarayana Chava, Founder and CEO of Laurus Labs Private Limited, India, today announced that the company has launched Laurus Synthesis Inc., a new U.S. pharmaceutical and biotech services entity. Laurus Synthesis Inc. will operate under the ...
read more
LaunchWorks CDMO has been approved to manufacture and distribute Viral Transport Media, in accordance with Section IV.B of the FDA’s COVID-19 Transport Media Policy.
read more
LaunchWorks Manufacturing Lab, a company serving the life science market, is now LaunchWorks CDMO.
read more
Wednesday, February 13, 2013
Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced that the U.S. Food and Drug Administration (FDA) has granted approval of a Supplemental New Drug ...
read more
Lantern Pharma announced agreements with contract manufacturing companies for process development and manufacturing for two of Lantern's oncology drug candidates, LP-300 and LP-184.
read more
Wednesday, November 01, 2017
Lannett has entered into a settlement and license agreement with Celgene Corporation that resolves patent infringement litigation in the U.S. related to Celgene's Thalomid.
read more
Monday, December 23, 2019
Lannett has received approvals from the FDA of its ANDAs for Butalbital, Acetaminophen and Caffeine Capsules.
read more
Lannett has entered into separate agreements with three strategic alliance partners.
read more
LakePharma has announced the launch of GMP manufacturing of recombinant proteins and antibodies with CHO-GSN™ and TunaCHO™ platforms at its Hayward, California facility.
read more
LakePharma announced their GMP biorepository facility is now commercially operational at their Hopkinton, MA location, which is in close proximity to the Cambridge and Boston areas.
read more
Tuesday, February 13, 2018
LakePharma announced the launch of the LakePharma MicroBiomanufacturing (GMP) Center in Hopkinton, MA.
read more
Friday, December 09, 2022
Labcorp has begun operations at a new, larger anatomic pathology and histology (APH) laboratory in Los Angeles, expanding the company’s global central laboratory capabilities.
read more
Wednesday, February 26, 2020
The FDA has sent a warning letter to KVK-Tech regarding "significant violations of CGMP regulations for finished pharmaceuticals."
read more
Tuesday, November 14, 2017
VK Tech announced a partnership with Productos Medix in Mexico.
read more